GENEVA, Nov. 11 -- NOVACCESS GLOBAL INC. (8584 E. Washington Street #127Chagrin Falls, Ohio 44023) filed a patent application (PCT/US2025/027195) for "IDH1 AS A BIOMARKER AND ENHANCER OF CANCER IMMUNOTHERAPY" on Apr 30, 2025. With publication no. WO/2025/231195, the details related to the patent application was published on Nov 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WHEELER, Christopher (NovAccess Global Inc.8584 E. Washington Street #127Chagrin Falls, Ohio 44023)
Abstract: The present invention provides for a method of treating brain tumors, particularly gliomas and glioblasto...